The Food and Drug Administration today reported 55 injuries and one death involving an infusion pump and vital signs monitoring system. Becton Dickinson CareFusion 303 Inc. recalled the Alaris Infusion Pump System and Modules in February due to software and other errors that can delay, speed or interrupt the infusion of medications and other fluids to patients. According to FDA, consumers should follow the manufacturer’s recommended actions to help mitigate the potential risk of errors until the software issues have been remediated. Health care providers may report associated adverse reactions or quality problems to FDA’s MedWatch reporting program.

Related News Articles

Headline
Cordis Corporation recently recalled 25,000 catheters used to visualize and measure parts of the vascular system, due to the potential for their marker…
Headline
President Biden Friday added measles to the list of quarantinable diseases, as recommended by Health and Human Services Secretary Xavier Becerra and…
Headline
The AHA and its Institute for Diversity and Health Equity are now accepting applications for the 2022 Carolyn Boone Lewis Equity of Care Awards. The…
Headline
The Centers for Disease Control and Prevention will invest $2.1 billion from the American Rescue Plan Act to help public health and other partners fight COVID-…
Blog
Post-acute care (PAC) providers continue to play a central role in COVID-19 response and recovery. In particular, providers in COVID-19 hotspots have been…
Headline
The AHA is accepting applications through Oct. 15 for its 2022 Quest for Quality Prize. The prize honors hospitals and health systems that have demonstrated…